Back to results
US 6,677,357 B2Granted
Rapamycin 29-enols
AssigneeWyeth
InventorsTianmin Zhu, Mahdi B. Fawzi
Life of this patent
Estimating the term…
Abstract
This invention provides non-immunosuppressive rapamycin 29-enols, which are useful as neurotrophic agents, in the treatment of solid tumors, and vascular disease.
Claims10
A compound which is a rapamycin 29-enol, said compound having the structure:
- or a pharmaceutically acceptable salt thereof.
The compound 42-O-(2-hydroxy)ethyl rapamycin 29-enol.
Dependencies are inferred from the claim text.